{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:08:30Z","timestamp":1782274110629,"version":"3.54.5"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2022-NR067412"],"award-info":[{"award-number":["RS-2022-NR067412"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2022-NR067425"],"award-info":[{"award-number":["RS-2022-NR067425"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108875","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:04:04Z","timestamp":1755551044000},"page":"108875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Flavonoid-based dual modulation of GPR120 and PPAR\u03b3: A potential therapeutic strategy for metabolic disease intervention"],"prefix":"10.1016","volume":"164","author":[{"given":"Geetanjali B.","family":"Gone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenogmok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Seul","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibeom","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungbin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang J.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bioorg.2025.108875_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/nu16050647","article-title":"Exploring the anti-diabetic potential of Quercetagitrin through dual inhibition of PTPN6 and PTPN9","volume":"16","author":"Gone","year":"2024","journal-title":"Nutrients"},{"issue":"22","key":"10.1016\/j.bioorg.2025.108875_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/nu15224774","article-title":"Identification of crocetin as a dual agonist of GPR40 and GPR120 responsible for the antidiabetic effect of saffron","volume":"15","author":"Zhao","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bioorg.2025.108875_bb0015","doi-asserted-by":"crossref","unstructured":"I. Kimura, A. Ichimura, R. Ohue-Kitano, and M. Igarashi, \"Free fatty acid receptors in health and disease,\" Physiol. Rev., vol. 100, no. 1, pp. 171\u2013210, Jan 1 2020, doi: https:\/\/doi.org\/10.1152\/physrev.00041.2018.","DOI":"10.1152\/physrev.00041.2018"},{"issue":"22","key":"10.1016\/j.bioorg.2025.108875_bb0020","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMra2216691","article-title":"Adipocyte regulation of insulin sensitivity and the risk of type 2 diabetes","volume":"388","author":"Santoro","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108875_bb0025","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1021\/acs.jmedchem.0c01002","article-title":"GPR120\/FFAR4 pharmacology: focus on agonists in type 2 diabetes mellitus drug discovery","volume":"64","author":"Carullo","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108875_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/8056440","article-title":"A comprehensive review on weight gain following discontinuation of glucagon-like peptide-1 receptor agonists for obesity","volume":"2024","author":"Abdullah Bin Ahmed","year":"2024","journal-title":"J. Obes."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108875_bb0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/oby.23622","article-title":"Real-world weight-loss effectiveness of glucagon-like peptide-1 agonists among patients with type 2 diabetes: a retrospective cohort study","volume":"31","author":"White","year":"2023","journal-title":"Obesity (Silver Spring)"},{"issue":"13","key":"10.1016\/j.bioorg.2025.108875_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310449","article-title":"Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials","volume":"24","author":"Popoviciu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108875_bb0045","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108875_bb0050","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/pr.112.007179","article-title":"International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands","volume":"65","author":"Davenport","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108875_bb0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/ijms17040450","article-title":"Nutritional Signaling via free fatty acid receptors","volume":"17","author":"Miyamoto","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108875_bb0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrd.2015.4","article-title":"G protein-coupled receptors as targets for anti-diabetic therapeutics","volume":"15","author":"Oh","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108875_bb0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd3777","article-title":"G protein-coupled receptors for energy metabolites as new therapeutic targets","volume":"11","author":"Blad","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108875_bb0070","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/acs.jmedchem.1c00031","article-title":"Structure-activity relationship study and biological evaluation of 2-(disubstituted phenyl)-indole-5-propanoic acid derivatives as GPR40 full agonists","volume":"64","author":"Zhao","year":"2021","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108875_bb0075","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108875_bb0080","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints","volume":"63","author":"Fredriksson","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"33","key":"10.1016\/j.bioorg.2025.108875_bb0085","doi-asserted-by":"crossref","first-page":"20438","DOI":"10.1074\/jbc.M115.657379","article-title":"Endogenous ligand for GPR120, docosahexaenoic acid, exerts benign metabolic effects on the skeletal muscles via AMP-activated protein kinase pathway","volume":"290","author":"Kim","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108875_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbalip.2017.11.002","article-title":"Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120)","volume":"1863","author":"Kang","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"15","key":"10.1016\/j.bioorg.2025.108875_bb0095","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00018-017-2492-2","article-title":"GPR120: a critical role in adipogenesis, inflammation, and energy metabolism in adipose tissue","volume":"74","author":"Song","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108875_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26226907","article-title":"Novel GPR120 agonists with improved pharmacokinetic profiles for the treatment of type 2 diabetes","volume":"26","author":"Ji","year":"2021","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108875_bb0105","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1039\/D1RA08925K","article-title":"Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes","volume":"12","author":"Wang","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.108875_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.816014","article-title":"Fluorescent ligand-based discovery of small-molecule Sulfonamide agonists for GPR120","volume":"10","author":"Ma","year":"2022","journal-title":"Front. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108875_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062501","article-title":"Potential therapeutic exploitation of G protein-coupled receptor 120 (GPR120\/FFAR4) signaling in obesity-related metabolic disorders","volume":"26","author":"Szukiewicz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108875_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1177897","article-title":"Role of flavonoids in controlling obesity: molecular targets and mechanisms","volume":"10","author":"Mahboob","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.bioorg.2025.108875_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104657","article-title":"Pinocembrin and its linolenoyl ester derivative induce wound healing activity in HaCaT cell line potentially involving a GPR120\/FFA4 mediated pathway","volume":"108","author":"Mazzotta","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108875_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbrc.2022.09.099","article-title":"Vaccarin improves insulin sensitivity and glucose uptake in diet-induced obese mice via activation of GPR120-PI3K\/AKT\/GLUT4 pathway","volume":"634","author":"Jia","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108875_bb0135","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1021\/np040079b","article-title":"Semisynthesis of linarin, acacetin, and 6-iodoapigenin derivatives from diosmin","volume":"67","author":"Quintin","year":"2004","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108875_bb0140","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/cbic.201900467","article-title":"Discovery of small-molecule modulators of protein-RNA interactions by fluorescence intensity-based binding assay","volume":"21","author":"Byun","year":"2020","journal-title":"Chembiochem"},{"key":"10.1016\/j.bioorg.2025.108875_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123740","article-title":"A novel lipophenol quercetin derivative to prevent macular degeneration: intravenous and oral formulations for preclinical pharmacological evaluation","volume":"651","author":"Vincent","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.108875_bb0150","series-title":"\u201cPyrazolylbenzene-1, 3-Diols for Diseases Associated with g Protein-Coupled Receptor 18 and in Combination with Transient Receptor Potential Vanilloid 1,\u201d Ed: Google Patents","author":"Abood","year":"2024"},{"issue":"24","key":"10.1016\/j.bioorg.2025.108875_bb0155","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1039\/C5OB01984B","article-title":"Enantioselective oxidative boron heck reactions","volume":"14","author":"Lee","year":"2016","journal-title":"Org. Biomol. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108875_bb0160","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm.3614","article-title":"A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice","volume":"20","author":"Oh","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2025.108875_bb0165","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.biopha.2018.08.073","article-title":"Biochanin a improves insulin sensitivity and controls hyperglycemia in type 2 diabetes","volume":"107","author":"Oza","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108875_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.607796","article-title":"Acacetin protects against high glucose-induced endothelial cells injury by preserving mitochondrial function via activating Sirt1\/Sirt3\/AMPK signals","volume":"11","author":"Han","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108875_bb0175","doi-asserted-by":"crossref","unstructured":"X. Zhang et al., \"Structural basis for the ligand recognition and signaling of free fatty acid receptors,\" Sci. Adv., vol. 10, no. 2, p. eadj2384, 2 2024, doi: https:\/\/doi.org\/10.1126\/sciadv.adj2384.","DOI":"10.1126\/sciadv.adj2384"},{"key":"10.1016\/j.bioorg.2025.108875_bb0180","doi-asserted-by":"crossref","unstructured":"C. Mao et al., \"Unsaturated bond recognition leads to biased signal in a fatty acid receptor,\" Science, vol. 380, no. 6640, p. eadd6220, Apr 7 2023, doi: https:\/\/doi.org\/10.1126\/science.add6220.","DOI":"10.1126\/science.add6220"},{"issue":"23","key":"10.1016\/j.bioorg.2025.108875_bb0185","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1111\/febs.15310","article-title":"GPR120 facilitates cholesterol efflux in macrophages through activation of AMPK signaling pathway","volume":"287","author":"An","year":"2020","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108875_bb0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s40200-024-01420-8","article-title":"AMPK pathway: an emerging target to control diabetes mellitus and its related complications","volume":"23","author":"Kakoti","year":"2024","journal-title":"J. Diabetes Metab. Disord."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108875_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40200-022-01155-4","article-title":"Natural activators of AMPK signaling: potential role in the management of type-2 diabetes","volume":"22","author":"Chauhan","year":"2023","journal-title":"J. Diabetes Metab. Disord."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108875_bb0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/cbf.3767","article-title":"AMP-activated protein kinase is a key regulator of obesity-associated factors","volume":"41","author":"Mohseni","year":"2023","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bioorg.2025.108875_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112563","article-title":"AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: a pre-clinical and clinical investigation","volume":"146","author":"Entezari","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"21","key":"10.1016\/j.bioorg.2025.108875_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111409","article-title":"Saikosaponin a and d inhibit adipogenesis via the AMPK and MAPK signaling pathways in 3T3-L1 adipocytes","volume":"22","author":"Lim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"36","key":"10.1016\/j.bioorg.2025.108875_bb0215","doi-asserted-by":"crossref","first-page":"22958","DOI":"10.1021\/acsomega.0c02525","article-title":"Laquinimod prevents adipogenesis and obesity by down-regulating PPAR-gamma and C\/EBPalpha through activating AMPK","volume":"5","author":"Wang","year":"2020","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108875_bb0220","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1096\/fj.201700231RR","article-title":"Vanillic acid attenuates obesity via activation of the AMPK pathway and thermogenic factors in vivo and in vitro","volume":"32","author":"Jung","year":"2018","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108875_bb0225","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1039\/C4FO00470A","article-title":"The AMPK pathway mediates an anti-adipogenic effect of fruits of Hovenia dulcis Thunb","volume":"5","author":"Kim","year":"2014","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108875_bb0230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ptr.2606","article-title":"Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways","volume":"23","author":"Hwang","year":"2009","journal-title":"Phytother. Res."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108875_bb0235","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.tem.2023.08.011","article-title":"Metabolic control by AMPK in white adipose tissue","volume":"34","author":"Goransson","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108875_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.81","article-title":"Regulation and function of AMPK in physiology and diseases","volume":"48","author":"Jeon","year":"2016","journal-title":"Exp. Mol. Med."},{"issue":"46","key":"10.1016\/j.bioorg.2025.108875_bb0245","doi-asserted-by":"crossref","first-page":"47898","DOI":"10.1074\/jbc.M408149200","article-title":"AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells","volume":"279","author":"Zang","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108875_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-04394-0","article-title":"GPR120 induces regulatory dendritic cells by inhibiting HK2-dependent glycolysis to alleviate fulminant hepatic failure","volume":"13","author":"Yu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108875_bb0255","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1210\/en.2018-00284","article-title":"FFAR4 is involved in regulation of neurotensin release from neuroendocrine cells and male C57BL\/6 mice","volume":"159","author":"Li","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.bioorg.2025.108875_bb0260","doi-asserted-by":"crossref","unstructured":"Hilgendorf, K. I. et al Omega-3 fatty acids activate ciliary FFAR4 to control adipogenesis. Cell, 179, 6, 1289-1305 e21, Nov 27 2019, https:\/\/doi.org\/10.1016\/j.cell.2019.11.005.","DOI":"10.1016\/j.cell.2019.11.005"},{"key":"10.1016\/j.bioorg.2025.108875_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2016.06.009","article-title":"GPR120 promotes adipogenesis through intracellular calcium and extracellular signal-regulated kinase 1\/2 signal pathway","volume":"434","author":"Song","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108875_bb0270","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/mol.113.087783","article-title":"The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism","volume":"84","author":"Hudson","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108875_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111714","article-title":"Inverse agonism of the FFA4 free fatty acid receptor controls both adipogenesis and mature adipocyte function","volume":"131","author":"Alshammari","year":"2025","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108875_bb0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ame2.12042","article-title":"Obese zebrafish: a small fish for a major human health condition","volume":"1","author":"Faillaci","year":"2018","journal-title":"Animal Model Exp Med"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108875_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105372","article-title":"Zebrafish: a new promise to study the impact of metabolic disorders on the brain","volume":"23","author":"Ghaddar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108875_bb0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1538\/expanim.18-0168","article-title":"The promise of zebrafish as a model of metabolic syndrome","volume":"68","author":"Benchoula","year":"2019","journal-title":"Exp. Anim."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108875_bb0295","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1152\/physrev.00038.2016","article-title":"Little fish, big data: zebrafish as a model for cardiovascular and metabolic disease","volume":"97","author":"Gut","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bioorg.2025.108875_bb0300","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2017.08.007","article-title":"Catching new targets in metabolic disease with a zebrafish","volume":"37","author":"Kamel","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108875_bb0305","doi-asserted-by":"crossref","unstructured":"R. S. Angom and N. M. R. Nakka, \"Zebrafish as a model for cardiovascular and metabolic disease: the future of precision medicine,\" Biomedicines, vol. 12, no. 3, Mar 20 2024, doi: https:\/\/doi.org\/10.3390\/biomedicines12030693.","DOI":"10.3390\/biomedicines12030693"},{"key":"10.1016\/j.bioorg.2025.108875_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2018.00091","article-title":"Zebrafish as a model for obesity and diabetes","volume":"6","author":"Zang","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108875_bb0315","article-title":"Zebrafish: a model to study and understand the diabetic nephropathy and other microvascular complications of type 2 diabetes mellitus","volume":"9","author":"Sharchil","year":"2022","journal-title":"Vet. Sci."},{"issue":"17\u201318","key":"10.1016\/j.bioorg.2025.108875_bb0320","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1101\/gad.348261.121","article-title":"Discovery of ciliary G protein-coupled receptors regulating pancreatic islet insulin and glucagon secretion","volume":"35","author":"Wu","year":"2021","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2025.108875_bb0325","unstructured":"P. Misra and R. Chakrabarti, \"The role of AMP kinase in diabetes,\" Indian J. Med. Res., vol. 125, no. 3, pp. 389\u201398, 2007. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17496363."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108875_bb0330","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4014\/jmb.1802.01065","article-title":"Acer okamotoanum Nakai leaf extract inhibits adipogenesis via suppressing expression of PPAR gamma and C\/EBP alpha in 3T3-L1 cells","volume":"28","author":"Kim","year":"2018","journal-title":"J. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108875_bb0335","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11033-020-06036-8","article-title":"Molecular mechanism of down-regulating adipogenic transcription factors in 3T3-L1 adipocyte cells by bioactive anti-adipogenic compounds","volume":"48","author":"Guru","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108875_bb0340","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","article-title":"Adiponectin, the past two decades","volume":"8","author":"Wang","year":"2016","journal-title":"J. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108875_bb0345","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)81654-2","article-title":"PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function","volume":"99","author":"Lowell","year":"1999","journal-title":"Cell"},{"issue":"6785","key":"10.1016\/j.bioorg.2025.108875_bb0350","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108875_bb0355","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1172\/JCI12864","article-title":"Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes","volume":"108","author":"Yamauchi","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2025.108875_bb0360","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/549101","article-title":"AMPK-dependent metabolic regulation by PPAR agonists","volume":"2010","author":"Lee","year":"2010","journal-title":"PPAR Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108875_bb0365","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1097-2765(00)80210-5","article-title":"PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance","volume":"4","author":"Kubota","year":"1999","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108875_bb0370","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.1152\/ajpendo.00453.2005","article-title":"Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues","volume":"291","author":"LeBrasseur","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"28","key":"10.1016\/j.bioorg.2025.108875_bb0375","doi-asserted-by":"crossref","first-page":"25226","DOI":"10.1074\/jbc.M202489200","article-title":"The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways","volume":"277","author":"Fryer","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108875_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048874","article-title":"Cross regulation of sirtuin 1, AMPK, and PPARgamma in conjugated linoleic acid treated adipocytes","volume":"7","author":"Jiang","year":"2012","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108875_bb0385","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12774","article-title":"Antagonizing peroxisome proliferator-activated receptor gamma facilitates M1-to-M2 shift of microglia by enhancing autophagy via the LKB1-AMPK signaling pathway","volume":"17","author":"Ji","year":"2018","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108875_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.04.020","article-title":"Positive reinforcing mechanisms between GPR120 and PPARgamma modulate insulin sensitivity","volume":"31","author":"Paschoal","year":"2020","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108875_bb0395","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1039\/C6SC01279E","article-title":"Mechanistic elucidation guided by covalent inhibitors for the development of anti-diabetic PPARgamma ligands","volume":"7","author":"Bae","year":"2016","journal-title":"Chem. Sci."},{"issue":"7365","key":"10.1016\/j.bioorg.2025.108875_bb0400","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature10383","article-title":"Antidiabetic actions of a non-agonist PPARgamma ligand blocking Cdk5-mediated phosphorylation","volume":"477","author":"Choi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108875_bb0405","doi-asserted-by":"crossref","first-page":"19288","DOI":"10.1038\/srep19288","article-title":"Dietary component isorhamnetin is a PPARgamma antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108875_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115037","article-title":"Ginsenoside re inhibits melanogenesis and melanoma growth by downregulating microphthalmia-associated transcription factor","volume":"165","author":"Hwang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108875_bb0415","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.metabol.2017.02.002","article-title":"A synthetic Nitraria alkaloid, isonitramine protects pancreatic beta-cell and attenuates postprandial hyperglycemia","volume":"70","author":"Kwon","year":"2017","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108875_bb0420","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41418-021-00911-y","article-title":"miR-125a-5p attenuates macrophage-mediated vascular dysfunction by targeting Ninjurin1","volume":"29","author":"Hwang","year":"2022","journal-title":"Cell Death Differ."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:48:38Z","timestamp":1757656118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825007552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":84,"alternative-id":["S0045206825007552"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108875","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flavonoid-based dual modulation of GPR120 and PPAR\u03b3: A potential therapeutic strategy for metabolic disease intervention","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108875"}}